Inhibition of acid sphingomyelinase increases regulatory T cells in humans.
acid sphingomyelinase
antidepressants
major depression
regulatory T cells
sphingolipids
Journal
Brain communications
ISSN: 2632-1297
Titre abrégé: Brain Commun
Pays: England
ID NLM: 101755125
Informations de publication
Date de publication:
2021
2021
Historique:
received:
29
04
2020
revised:
11
11
2020
accepted:
15
12
2020
entrez:
26
4
2021
pubmed:
27
4
2021
medline:
27
4
2021
Statut:
epublish
Résumé
Genetic deficiency for acid sphingomyelinase or its pharmacological inhibition has been shown to increase Foxp3
Identifiants
pubmed: 33898989
doi: 10.1093/braincomms/fcab020
pii: fcab020
pmc: PMC8054263
doi:
Types de publication
Journal Article
Langues
eng
Pagination
fcab020Informations de copyright
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.
Références
Nat Rev Mol Cell Biol. 2008 Feb;9(2):112-24
pubmed: 18216768
Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):7225-30
pubmed: 26015572
Blood. 2008 Aug 15;112(4):1175-83
pubmed: 18523152
Cell Physiol Biochem. 2016;39(3):985-95
pubmed: 27512981
Science. 2008 Oct 10;322(5899):271-5
pubmed: 18845758
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
J Exp Med. 1994 Oct 1;180(4):1547-52
pubmed: 7523573
Nat Rev Mol Cell Biol. 2018 Mar;19(3):175-191
pubmed: 29165427
Nat Immunol. 2016 May;17(5):556-64
pubmed: 26974206
Eur J Immunol. 2013 Jan;43(1):188-93
pubmed: 23065717
J Immunol. 2003 Oct 1;171(7):3348-52
pubmed: 14500627
J Immunol. 2016 Oct 15;197(8):3130-3141
pubmed: 27638864
JAMA Psychiatry. 2013 Jan;70(1):31-41
pubmed: 22945416
Am J Psychiatry. 2008 Mar;165(3):342-51
pubmed: 18172020
Nat Rev Immunol. 2011 Nov 25;11(12):852-63
pubmed: 22116087
J Exp Med. 1995 Jun 1;181(6):2059-68
pubmed: 7759998
J Immunol. 2015 Mar 1;194(5):2148-59
pubmed: 25632005
Front Immunol. 2018 May 16;9:1060
pubmed: 29868020
Eur J Immunol. 2018 Aug;48(8):1376-1388
pubmed: 29719048
Blood. 2011 Dec 22;118(26):6772-82
pubmed: 21931118
Nat Rev Immunol. 2013 Apr;13(4):227-42
pubmed: 23470321
PLoS One. 2011;6(8):e23852
pubmed: 21909365
Trends Immunol. 2008 Apr;29(4):150-8
pubmed: 18328783
Chem Commun (Camb). 2017 Jun 22;53(51):6836-6839
pubmed: 28597878
Neurosignals. 2017;25(1):88-97
pubmed: 29131010
Nat Immunol. 2005 Nov;6(11):1152-9
pubmed: 16227983
FEBS Lett. 2006 Aug 21;580(19):4751-6
pubmed: 16901483
J Psychiatr Res. 2010 Nov;44(15):1052-7
pubmed: 20413130
Front Immunol. 2019 Oct 11;10:2363
pubmed: 31681273
J Affect Disord. 2010 Jul;124(1-2):68-75
pubmed: 19900711
J Exp Med. 2018 Sep 3;215(9):2463-2476
pubmed: 30115741
Nat Immunol. 2014 Nov;15(11):1070-8
pubmed: 25263123
Front Physiol. 2014 Sep 02;5:331
pubmed: 25228885
J Clin Invest. 2013 Feb;123(2):580-93
pubmed: 23281398
J Immunol. 2016 May 1;196(9):3951-62
pubmed: 27036914
Immunity. 2000 Apr;12(4):431-40
pubmed: 10795741
J Exp Med. 2004 Aug 2;200(3):277-85
pubmed: 15280421
J Exp Med. 2004 Apr 5;199(7):971-9
pubmed: 15067033
Nat Rev Neurosci. 2008 Jan;9(1):46-56
pubmed: 18073775
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1027-31
pubmed: 18450787
J Exp Med. 2015 Sep 21;212(10):1603-21
pubmed: 26371185
Neuropsychopharmacology. 2013 Aug;38(9):1607-8
pubmed: 23857540
Nat Immunol. 2005 Nov;6(11):1142-51
pubmed: 16227984
Mol Psychiatry. 2018 Feb;23(2):335-343
pubmed: 27752078
Science. 2011 Apr 29;332(6029):600-3
pubmed: 21474713
JAMA Psychiatry. 2014 Dec 1;71(12):1381-91
pubmed: 25322082
Nat Med. 2013 Jul;19(7):934-8
pubmed: 23770692
Immunity. 2009 Jun 19;30(6):899-911
pubmed: 19464196
J Immunol. 2002 May 1;168(9):4420-9
pubmed: 11970985